Figure 3.

CCR6 mRNA PBMCs. CCR6 mRNA in PBMCs (n = 38) from healthy controls (N), active ulcerative colitis (UCa) inactive ulcerative colitis (UCi), active Crohn’s disease (CDa) and inactive Crohn’s disease (CDi). Fold changes were determined relative to mean expression of the reference genes beta actin, TATA binding protein and eukaryote 18s rRNA and to the mean expression level in N. Individual fold change and median are plotted. Statistical comparison was performed using Kruskal-Wallis test followed by Mann-Whitney test with levels of significance denoted by * p < 0.05 and ** p < 0.01.